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Abstract
Variations in the balance between cell proliferation and apoptosis could contribute to the etiology of
gingival overgrowth. The aim of this study was to test the hypothesis that, in fibrotic gingival lesions,
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forms of gingival overgrowth tested, independent of inflammation (p < 0.05). To identify potential
mechanisms of transcriptional regulation of apoptosis, we assessed FOXO1 and caspase 3 expression
levels and found them to correlate well with diminished apoptosis. Analysis of data suggests that
increased fibroblast proliferation and a simultaneous decrease in apoptosis contribute to gingival
overgrowth.
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Abstract
Variations in the balance between cell proliferation and apoptosis could contribute to the etiology
of gingival overgrowth. The aim of this study was to test the hypothesis that, in fibrotic gingival
lesions, fibroblast proliferation is stimulated and apoptosis is decreased. Apoptotic index, caspase
3 expression, the proliferative index, FOXO1 expression, and histological inflammation were
measured in situ. Analysis of data showed that apoptosis decreased in all forms of gingival
overgrowth examined (p < 0.05), and inflammation caused a small but significant increase
compared with non-inflamed tissues (p < 0.05). The greatest decrease of apoptosis occurred in the
most fibrotic tissues. Cell proliferation was elevated in all forms of gingival overgrowth tested,
independent of inflammation (p < 0.05). To identify potential mechanisms of transcriptional
regulation of apoptosis, we assessed FOXO1 and caspase 3 expression levels and found them to
correlate well with diminished apoptosis. Analysis of data suggests that increased fibroblast
proliferation and a simultaneous decrease in apoptosis contribute to gingival overgrowth.
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INTRODUCTION
Cell division and death maintain the balance among cell populations in an organism (Chen
and Zychlinsky, 1994). Apoptosis is a highly regulated form of programmed cell death,
defined by distinct morphological and biochemical features (Vaux and Strasser, 1996; Peter
et al., 1997b). Abnormal apoptosis has been implicated in various pathologies, e.g., cancer,
AIDS, Alzheimer's disease, rheumatoid arthritis (Thompson, 1995; Peter et al., 1997a; Liu et
al., 2006), periodontal diseases (Tonetti et al., 1998; Jarnbring et al., 2002; Bantel et al.,
2005), and diabetes (Alikhani et al., 2005a; Graves et al., 2006). Apoptosis can be
modulated by mediators of inflammation (Dalgleish and O'Byrne, 2006; Graves et al.,
2006).
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Intracellular signaling pathways regulate apoptosis, and caspase 3 plays a pivotal role
regardless of the activation signal (Vaux and Strasser, 1996; Peter et al., 1997b; Alikhani et
al., 2004; Bantel et al., 2005). The Akt/PI3 kinase pathway can regulate gene expression
through control of the Forkhead (FOXO) transcription factors (Kaufmann, 1996; Brunet et
al., 1998; Burgering and Kops, 2002; Schmidt et al., 2002; Stahl et al., 2002). Activation of
FOXOs by dephosphorylation leads to cell cycle arrest (Medema et al., 2000) and alterations
in energy metabolism (Barthel et al., 2002), and FOXOs play critical roles in the regulation
of proliferation and oxidative stress (Birkenkamp and Coffer, 2003). FOXO activation can
result in the induction of apoptosis (Ciechomska et al., 2003; Ghaffari et al., 2003; Hu et al.,
2004; Seoane et al., 2004), while inactivation of FOXO proteins disrupts the critical balance
between cell proliferation and cell death and contributes to tumorigenesis by promoting cell
growth and cell survival (Arden, 2006). Inflammation can also increase FOXO expression,
as demonstrated by tumor necrosis factor alpha (TNF-α), activating FOXO in vitro and in
vivo, while TNF-α-stimulated fibroblast apoptosis was reduced 76% when FOXO was
silenced (Alikhani et al., 2005b). FOXO is also associated with caspase-mediated apoptosis,
as evidenced by inhibition of FOXO, which led to a reduced activation of caspases-3, −8,
and −9 in response to TNF-α, indicating that FOXO-regulated genes played an important
role in the signaling events leading to apoptosis, and identifying the activation of FOXO as a
critical step in the capacity of TNF-α to stimulate the apoptosis of fibroblasts (Alikhani et
al., 2005b).
In healing tissues, the transition from a granulation tissue to a remodeling tissue requires the
apoptosis of fibroblasts. Wounds in which there is inadequate apoptosis may result in the
formation of fibrotic tissues. Thus, modulation of apoptosis could contribute to the etiology
of fibrosis in gingival tissues. The balance between cell proliferation and apoptosis may be
characteristic of different forms of gingival overgrowth, and variations in this balance may
provide insights into different etiologies in different forms of gingival overgrowth. For
example, phenytoin-induced gingival overgrowth and inherited gingival fibromatosis appear
to be more fibrotic than other forms of gingival overgrowth (Uzel et al., 2001; Casavecchia
et al., 2004; Trackman and Kantarci, 2004; Kantarci et al., 2006). A working hypothesis is
that, in hypercellular and fibrotic lesions, fibroblast proliferation may be stimulated, whereas
in lesions containing high levels of extracellular matrix and fewer cells, fibroblast apoptosis
may be stimulated. In this study, we investigated in situ the balance between apoptosis and
proliferation in different forms of gingival overgrowth and the expression of caspase 3 and
FOXO1, to gain potentially new insights into the etiology of different forms of gingival
overgrowth.

MATERIALS & METHODS
Gingival Tissues
Gingival tissue samples were obtained from persons undergoing periodontal surgery in the
Department of Periodontology and Oral Biology and the Clinical Research Center of Boston
University, the Franciscan Children's Hospital and Rehabilitation Center, Boston, MA, and
the Department of Periodontology of the University of Istanbul. In total, samples from 40
donors were included in the study. Classification of these samples was as follows:
phenytoin-induced gingival overgrowth (n = 8), cyclosporin-A-induced gingival overgrowth
(n = 7), nifedipine-induced gingival overgrowth (n = 7), hereditary gingival fibromatosis (n
= 12), and control tissues (n = 6) from systemically healthy donors without gingival
overgrowth. Consent from the donors was obtained prior to the study. The consent forms
were approved by the Institutional Review Board of Boston University Medical Center, the
Institutional Review Board of the Franciscan Children's Hospital and Rehabilitation Center,
and the Department of Periodontology of the University of Istanbul. All participants in this
study were 20 years of age or older. Age, gender, and clinical inflammation (gingival index
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and bleeding on probing) were recorded for each individual immediately prior to surgical
procedures. Gingivectomy and other periodontal surgical procedures were performed after
initial periodontal treatment, including professional elimination of supra- and subgingival
plaque and maintenance of proper oral hygiene; overall plaque accumulation was brought to
minimal (< 25% of all tooth surfaces). Upon excision, tissues were fixed in 4%
paraformaldehyde in PBS at 4°C for 4 hrs and then incubated in 30% sucrose overnight.
Tissues were then stored in 2-methylbutane at −80°C. At least 20 serial sections were made
on a cryostat, and stored at −80°C.
Immunohistochemistry and Histomorphometric Analyses
Immunohistochemistry was carried out with a temperature-controlled staining system to
standardize the staining conditions according to methods that we have previously described
(Hong et al., 1999; Uzel et al., 2001; Kantarci et al., 2006). Primary antibodies were
affinity-purified rabbit polyclonal antibodies against vimentin (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), active caspase-3 (Cell Signaling, Beverly, MA, USA), proliferative
cell nuclear antigen (PCNA; Santa Cruz, CA, USA), active FKHR/FOXO1A (Abcam,
Cambridge, MA, USA), and non-immune goat IgG controls. Quantitative
histomorphometric analyses of fibrosis, inflammation, and of immunostained sections were
performed as we have previously described (Uzel et al., 2001). Briefly, the orientation of
each sample and identification of tissue sites were determined at 100X and 400X
magnification; 5 sites with corresponding areas of 0.09 mm2 were defined and utilized for
quantitative analyses of immunohistochemical staining. The sites were chosen to represent
subepithelial connective tissue, subsulcular connective tissue, and deep connective tissue
(Uzel et al., 2001). Quantitation was performed by computer-assisted image analysis
(Image-Pro Plus 4.0, Media Cybernetics, Silver Spring, MD, USA), and data were collected
from 3 to 5 serial sections per tissue specimen per assay. We evaluated the results by
counting the number of stained cells per unit area, and used pre-immune stained slides from
serial sections as controls, to determine background staining, which was low or negligible.
We determined the number of inflammatory cells per 0.09 mm2 unit area from hematoxylinstained sections to assess the relative degree of inflammation, and we classified tissues
either as `highly inflamed' or as `not highly inflamed' (Uzel et al., 2001). Fibroblastic cells
were identified and quantitated per unit area in hematoxylin-and-eosin-stained sections,
based on morphological criteria in the same sections. The validity of the morphologic
criteria for fibroblast identification was confirmed by quantitative analyses of serial sections
stained with vimentin antibody.

TUNEL
We used the in situ TUNEL assay to detect apoptotic fibroblasts, using the TACS 2 TdT
(BTL) kit (Trevigen, Gaithersburg, MD, USA), following the manufacturer's instructions.
Apoptotic Index, Caspase 3 Expression, Proliferative Index
The apoptotic index was expressed as the percent of TUNEL-positive fibroblastic cells in
0.09 mm2 areas. Five areas per slide were measured in 3 to 5 serial sections per sample
(Uzel et al., 2001). Caspase 3 data were expressed as the percent of positive fibroblasts, and
data were collected in the same way as for the TUNEL assay. We determined the
proliferative index by measuring the percentage of PCNA-positive fibroblasts per unit area
in 5 areas per slide in 3 to 5 serial sections per sample.
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Statistical Analysis
Results are expressed as mean ± standard error of the mean for each evaluated site. For
statistical analysis, the Mann-Whitney test was used for the comparison of differences.
Significance was defined as p < 0.05.

RESULTS
Apoptosis in Fibrotic Gingiva
Apoptosis in gingival tissues was assessed by TUNEL assays. We determined the number of
TUNEL-positive fibroblasts and the total number of fibroblasts per unit area as a function of
all forms of gingival overgrowth and inflammation, to assess for any differences. In addition
to the total number of fibroblasts per unit area, TUNEL-positive fibroblasts were counted
and are presented (Table, A). Data were also expressed as the apoptotic index, or the percent
of TUNEL-positive fibroblasts (Fig. 1A). Results show that apoptosis was significantly
reduced in phenytoin-induced gingival overgrowth and in non-drug-induced gingival
fibromatosis tissues, compared with control and cyclosporin-A-induced gingival overgrowth
samples. Cyclosporin A and nifedipine samples also showed significantly less apoptosis
compared with controls. Inflammation led to increased apoptosis in non-fibrotic control
samples and in cyclosporin A and nifedipine samples. In phenytoin and gingival
fibromatosis samples, inflamed areas also showed significantly increased apoptosis
compared with non-inflamed sites, but the effect of inflammation may be less than for
control, cyclosporin A, and nifedipine samples (Fig. 1A).
Cell Proliferation in Connective Tissue
To investigate cell proliferation as a function of gingival overgrowth, we determined the
levels of PCNA (Table, B). This factor is required for DNA synthesis and is a marker for
actively dividing cells in vivo. We determined the proliferative index for all samples by
normalizing the PCNA-positive fibroblasts to the total number of fibroblasts in each section
(Fig. 1B). Phenytoin, cyclosporin A, nifedipine, and gingival fibromatosis samples showed
significantly higher cell proliferation over control samples. No effect of inflammation was
observed on the proliferative index, suggesting that all types of gingival overgrowth led to
increased fibroblast proliferation.
To assess independently for apoptosis and to gain mechanistic insights, we next performed
immunohisto chemistry to determine the in vivo expression of caspase 3. Measurement of
caspase 3 was performed because it is a pivotal enzyme in apoptosis in the two bestcharacterized pathways (Graves et al., 2006). Data are presented as the total number of
fibroblasts per unit area and the number of caspase-3-positive fibroblasts per unit area in
inflamed and non-inflamed areas of tissues (Table, C). In addition, data are expressed as the
percent caspase-3-positive fibroblasts, by analogy to the apoptotic index calculation (Fig. 2).
Similar to TUNEL, phenytoin and gingival fibromatosis samples showed the lowest caspase
3 expressions among the groups, with significant differences compared with control and
cyclosporin A samples. Nifedipine also contained significantly less caspase 3 than control
samples (Fig. 2). Comparisons of inflamed and non-inflamed sites revealed a trend toward
increased caspase 3 expression with inflammation, but the difference between caspase levels
as a function of inflammation was not statistically significant. Thus, trends in the apoptotic
index and the percent of caspase-3-positive cells were similar, though the absolute values of
these measurements differed as expected, since the assays measured different stages of the
process of apoptosis.
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FOXO1 Expression
FOXO1 is a regulator of apoptosis but, to our knowledge, has not been studied in fibrosis.
Data expressed as FOXO1-positive fibroblasts per unit area (0.09 mm2) revealed that
inflamed areas of control samples showed significantly higher immunostaining of FOXO1
(Fig. 3A). Phenytoin, cyclosporin A, nifedipine, and gingival fibromatosis samples also
showed higher levels of FOXO1 in areas where the inflammation was high (Fig. 3B). All
gingival fibrosis samples showed reduced FOXO1 expression in fibroblasts compared with
controls.

DISCUSSION
This study demonstrated that fibroblast apoptosis is decreased in gingival overgrowth, and
that this decrease may contribute to fibrosis, particularly in phenytoin-induced gingival
overgrowth and in gingival fibromatosis tissues. Phenytoin-induced gingival overgrowth and
gingival fibromatosis are the most fibrotic tissues, meaning that they contain the highest
proportion of fibroblastic cells and connective tissue fibers (Uzel et al., 2001; Kantarci et
al., 2006). Thus, increased fibroblast and extracellular matrix accumulation appears to be
due, in part, to diminished fibroblast cell death in these tissues. Nifedipine and cyclosporin
A tissues were more inflamed than phenytoin-induced gingival overgrowth and gingival
fibromatosis tissues. The apoptotic indices of nifedipine and cyclosporin A tissues were
higher than in phenytoin and gingival fibromatosis tissues, but lower than in normal control
tissues. Analysis of the data showed that inflammation led to an increase in apoptosis in 'no
overgrowth' control gingiva, and inflammation similarly appeared to stimulate apoptosis
within the context of gingival overgrowth, but to a lesser degree. Inflammation was the
lowest in phenytoin and gingival fibromatosis compared with other forms of gingival
overgrowth (Uzel et al., 2001; Kantarci et al., 2006). Whether lower inflammation in
phenytoin and gingival fibromatosis is a primary determining factor in the etiology of these
forms of gingival overgrowth is not known at the present time. It is interesting that
phenytoin-induced fibrosis and gingival fibromatosis contained high levels of CCN2/CTGF
(connective tissue growth factor), a marker of increased TGF-β1 activity (Uzel et al., 2001;
Kantarci et al., 2006). Because TGF-β1 suppresses the acquired immune response (Bottinger
et al., 1997), it seems possible that stimulation of a TGF-β1/CTGF pathway in gingival
fibromatosis and phenytoin-induced gingival overgrowth could, in turn, reduce gingival
inflammation and fibroblast apoptosis, and thereby contribute to gingival overgrowth.
Fibroblast cell proliferation increased in all forms of gingival overgrowth tested, regardless
of the level of inflammation. Thus, decreased apoptosis coupled with increased cell
proliferation together appear to contribute to all forms of gingival overgrowth. Decreased
fibroblast apoptosis appears to be particularly important in the development of the most
fibrotic forms of gingival overgrowth. Analyses performed by both the TUNEL assay and
determinations for caspase 3 levels support these findings.
Analysis of the data suggests that FOXO1 plays a role in the regulation of apoptosis in
fibrotic gingiva. FOXO1 is an important regulator of apoptosis. As noted earlier, FOXO1
has other biological roles as well (Barthel et al., 2002; Birkenkamp and Coffer, 2003). To
our knowledge, however, FOXO1 expression has not been studied in the context of fibrotic
diseases. Since FOXO activation leads to pro-apoptotic gene expression and, ultimately,
enhanced caspase 3 activation (Alikhani et al., 2005b), the finding that tissues with low
FOXO1 activation also have low caspase-3 activation is intriguing. To our knowledge, the
present study provides the first evidence of FOXO1 regulation in gingival tissues.
In conclusion, the data presented here provide evidence that decreased apoptosis possibly
mediated through diminished FOXO and caspase-3 expression, together with increased
J Dent Res. Author manuscript; available in PMC 2010 July 25.

Kantarci et al.

Page 6

proliferative activity in fibroblasts, could contribute to fibrotic overgrowth of gingival
tissues. The similarity between phenytoin-induced gingival overgrowth and non-medicationinduced gingival fibromatosis suggests that decreased gingival fibroblast apoptosis may
have different initiating causes, but is a particular characteristic of the most fibrotic tissues.
Moreover, inflammation increased apoptosis to a certain degree in all gingival tissues.
Further in vitro work is required to identify the pathways of inhibition of apoptosis in
gingival fibroblasts and tissues, and an increased understanding of these pathways could
ultimately provide opportunities for therapeutic interventions.
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Figure 1.

Apoptotic index (% TUNEL-positive fibroblasts) (A) and proliferative index (% PCNApositive fibroblasts) (B) in gingival overgrowth and control tissue samples. Data are
expressed as means ± SD. In (A), the numbers of independent samples (n) per group are: no
overgrowth control, 6; phenytoin overgrowth, 8; cyclosporin A overgrowth, 7; nifedipine
overgrowth, 7; and gingival fibromatosis, 12. *p < 0.05 compared with control, cyclosporin
A, and nifedipine; **p < 0.05 compared with control; #p < 0.05 compared with noninflamed. In (B), (n) per group is: control, 6; phenytoin, 6; cyclosporin A, 6; nifedipine, 6;
gingival and fibromatosis, 12. *p < 0.05 compared with control.
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Figure 2.

Caspase 3 expression in gingival tissues. Quantitative histomorphometric analyses of
caspase 3 immunostaining in all forms of gingival overgrowth in inflamed and non-inflamed
tissue areas (0.09 mm2). (n) per group is: control, 6; phenytoin, 8; cyclosporin A, 7;
nifedipine, 7; and gingival fibromatosis, 12. *p < 0.05 compared with control and
cyclosporin A; **p < 0.05 compared with control.
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Figure 3.

FOXO1 expression in gingival overgrowth and no overgrowth control tissues. (A)
Representative sections for the immunohistochemical staining of FOXO1 expression in
phenytoin and control tissues. Black arrows designate fibroblasts stained positive for
FOXO1. Each bar represents 200 μm at a magnification of 200×. (B) Histomorphometric
and quantitative analyses of FOXO1 immunostaining in all forms of gingival overgrowth in
inflamed and non-inflamed tissue areas (0.09 mm2). (n) for control, 6; for phenytoin, 6; for
cyclosporin A, 6; for nifedipine, 6; and for gingival fibromatosis, 8. *p < 0.05 compared
with control; #p < 0.05 compared with non-inflamed.
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0.2 ± 1.0* (15 ± 2%)

1.4 ± 3.9

Non-inflamed

TUNEL(+) Fibroblasts

Inflamed

165.4 ± 21.7§

146.7 ± 36.3§

171.4 ± 29.6

154.7 ± 32.4*§

187.3 ± 51.2

244.5 ± 51.2*#

208.4 ± 35.7*

214.5 ± 34.8*

289.8 ± 32.8*#

177.4 ± 35.6

Non-inflamed

Total Fibroblast Counts
Inflamed

82.8 ± 24.7§ (108
± 16%)

78.3 ± 26.9§ (103
± 16%)

69.8 ± 31.6 (92 ±
11%)

86.6 ± 11.8§ (114
± 22%)

76.0 ± 16.7

164.0 ± 31.0*# (264 ±
41%)

141.1 ± 21.7*# (227 ±
35%]

81.8 ± 24.2 (132 ±
26%)

167.4 ± 32.6*# (270
±33%)

62.4 ± 12.5

Non-inflamed

PCNA (+) Fibroblasts
Inflamed

B

162.2 ± 24.5§

176.4 ± 42.1§

181.5 ± 38.4

142.2 ± 22.2*§

221.7 ± 31.2

234.3 ± 43.1*#

212.0 ± 32.1*

198.4 ± 48.8*

325.8 ± 27.2*#

165.8 ± 21.6

Non-inflamed

Total Fibroblast Counts
Inflamed
8.3 ± 2.0

3.2 ± 1.6* (38 ±
9%)

4.3 ± 1.7 (52 ±
11%)

6.3 ± 1.5 (76 ±
13%)(52

2.1 ± 1.3* (28 ± 7%)

2.6 ± 1.9* (36 ± 6%)

3.8 ± 1.6* (52 ± 9%)

1.7 ± 1.4* (24 ± 7%)

7.3 ± 1.9

Non-inflamed

Caspase 3(+) Fibroblasts
Inflamed

2.5 ± 1.7* (30 ±
2%)

C

λ

Numbers in parentheses represent percent comparisons with control values.

p < 0.05 compared with non-inflamed. Inflamed areas are those having greater than 75 inflammatory cells/0.09 mm2; non-inflamed areas have fewer than 75 inflammatory cells/0.09 mm2.

p < 0.05 compared with Cyclosporin A and Nifedipine;

§

†

p < 0.05 compared with Cyclosporin A;

#

p < 0.05 compared with Control;

*

Data are expressed as mean ± SD per 0.09 mm2 area.

a

Independent samples per experimental group (n) are as follows: (for TUNEL) Control = 6, Phenytoin = 8, Cyclosporin A = 7, Nifedipine = 7, and Gingival Fibromatosis = 12; (for PCNA) Control = 6, Phenytoin = 6, Cyclosporin A = 6, Nifedipine = 6, Gingival Fibromatosis =
12; and (for Caspase 3 expression) Control = 6, Phenytoin = 7, Cyclosporin A = 7, Nifedipine = 6, and Gingival Fibromatosis = 11.

211.5 ± 48.9

162.2 ± 32.2*§

Phenytoin

Cyclosporin A

231.3 ± 33.2a

Control

Non-inflamed

Total Fibroblast Counts

Inflamed

A

Fibroblast Counts, TUNEL-positive (A), PCNA-positive (B), and Caspase-3-positive (C) Fibroblasts in Gingival Samples in Inflamed and Non-inflamed Sites
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